Literature DB >> 26808830

Brief Report: Severe Inflammation Following Vaccination Against Streptococcus pneumoniae in Patients With Cryopyrin-Associated Periodic Syndromes.

Ulrich A Walker1, Hal M Hoffman2, Rene Williams3, Jasmin Kuemmerle-Deschner4, Philip N Hawkins3.   

Abstract

OBJECTIVE: Pneumococcal vaccination is recommended for patients receiving immunosuppressive drugs. We describe unusually severe adverse reactions to pneumococcal vaccination in each of 7 consecutive patients with cryopyrin-associated periodic syndromes (CAPS).
METHODS: Seven consecutive patients with CAPS were vaccinated with pneumococcal polysaccharide or conjugate vaccines. Clinical information was collected retrospectively.
RESULTS: Within a few hours after the vaccination, all 7 patients developed severe local reactions at the injection site. Two patients had to be hospitalized for systemic reactions including fever. All symptoms resolved in a period of 3-17 days.
CONCLUSION: Our findings indicate that pneumococcal vaccines can trigger a severe local and systemic inflammatory reaction in patients with CAPS and possibly patients with other autoinflammatory diseases. Careful consideration is warranted when implementing current European League Against Rheumatism immunization guidelines in this patient population.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26808830     DOI: 10.1002/art.39482

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  13 in total

Review 1.  Autoinflammatory Diseases with Periodic Fevers.

Authors:  Erdal Sag; Yelda Bilginer; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 2.  [Autoinflammatory syndromes : Practical approach to diagnostics and therapy].

Authors:  J B Kümmerle-Deschner
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 3.  IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.

Authors:  Lori Broderick; Hal M Hoffman
Journal:  Nat Rev Rheumatol       Date:  2022-06-21       Impact factor: 32.286

4.  Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.

Authors:  Marc H Jansen; Christien Rondaan; Geertje Legger; Kirsten Minden; Yosef Uziel; Nataša Toplak; Despoina Maritsi; Mirjam van den Berg; Guy Berbers; Patricia Bruijning; Yona Egert; Christophe Normand; Marc Bijl; Helen Foster; Isabelle Kone-Paut; Carine Wouters; Angelo Ravelli; Ori Elkayam; Nicolaas M Wulffraat; Marloes W Heijstek
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

5.  Follow the complex bread crumbs: A review of autoinflammation for the general paediatrician.

Authors:  Paul Tsoukas; Ronald M Laxer
Journal:  Paediatr Child Health       Date:  2019-07-18       Impact factor: 2.253

6.  Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Authors:  Christien Rondaan; Victoria Furer; Marloes W Heijstek; Nancy Agmon-Levin; Marc Bijl; Ferdinand C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha C Kapetanovic; Jacob M van Laar; Annette Ladefoged de Thurah; Robert Landewé; Anna Molto; Ulf Müller-Ladner; Karen Schreiber; Leo Smolar; Jim Walker; Klaus Warnatz; Nico M Wulffraat; Sander van Assen; Ori Elkayam
Journal:  RMD Open       Date:  2019-09-09

Review 7.  Implications of COVID-19 in pediatric rheumatology.

Authors:  Ezgi Deniz Batu; Seza Özen
Journal:  Rheumatol Int       Date:  2020-06-04       Impact factor: 2.631

Review 8.  Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood.

Authors:  Tatjana Welzel; Susanne M Benseler; Jasmin B Kuemmerle-Deschner
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

9.  Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Authors' reply.

Authors:  Aysha H Al-Ani; Doug Johnson; Britt Christensen
Journal:  Aliment Pharmacol Ther       Date:  2020-09       Impact factor: 8.171

Review 10.  [Most important vaccinations in patients with rheumatological diseases and why].

Authors:  C Kneitz; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2020-09-21       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.